Fox Chase Cancer Center researchers introduced HOST-Factor, a quantitative scoring tool intended to characterize how radiation reprograms the pancreatic tumor microenvironment. The platform converts stromal traits into a single metric meant to help clinicians interpret and potentially tailor treatment after radiotherapy. The tool addresses a common clinical challenge in pancreatic ductal adenocarcinoma: radiation changes are heterogeneous across tumors, yet standard assessments often do not capture microenvironmental shifts in a way that translates to treatment selection. By producing a structured readout of stromal remodeling, HOST-Factor is designed to improve clinical decision-making around radiation-containing regimens. The report frames the method as a bridge between microenvironment biology and actionable oncology workflows. For the biotech sector, computational scoring tools that translate tissue phenotypes into decision variables remain a high-interest path for precision oncology diagnostics and trial enrichment.